Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganaxolone in infantile spasms (OLE)
NCT00442104Phase 2Terminated
- Sponsor
- Marinus Pharmaceuticals
- Start
- Jan 2007
- Primary completion
- Mar 2009
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of ganaxolone in infantile epileptic spasms syndrome (IESS), sponsored by Marinus Pharmaceuticals. Started Jan 2007; status: terminated.
02
Drugs
ganaxolone
03
Conditions
infantile epileptic spasms syndrome (IESS)
Beyond the preview
Go deeper on NCT00442104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442104.